ICBiotec

Mount Horeb, United States Founded: 1998 • Age: 28 yrs Acquired By eGenesis
Provider of gene editing platform for the development of human-compatible organs, tissues and cells
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About ICBiotec

ICBiotec is a company based in Mount Horeb (United States) founded in 1998 was acquired by eGenesis in May 2020. ICBiotec operates in a competitive market with competitors including Beam Therapeutics, eGenesis, Korro Bio, Metagenomi and Prime Medicine, among others.

  • Headquarter Mount Horeb, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    eGenesis

    (May 26, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ICBiotec

Premium access

Detailed funding history for ICBiotec

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in ICBiotec

ICBiotec has secured backing from 1 investor. Prominent investors backing the company include eGenesis.

All
Investor Description Founded Year Domain Location
Gene transplantation platform for humanizing pig cells is developed.
Locked Locked Locked
Premium access

Investor details for ICBiotec

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ICBiotec

Investments
Premium access

Investment portfolio details for ICBiotec

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - ICBiotec

Premium access

Detailed financials for ICBiotec

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Icbiotec Comparisons

ICBiotec Primary company
Description
Provider of gene editing platform for the development of hum...
Location
Mount Horeb, United States
Founded Year
1998
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for ICBiotec

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ICBiotec

ICBiotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beam Therapeutics, eGenesis, Korro Bio, Metagenomi and Prime Medicine, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of gene therapy using CRISPR base editing to treat diseases
Locked Locked Locked
Gene transplantation platform for humanizing pig cells is developed.
Locked Locked Locked
RNA-editing technologies are provided for precision medicine applications.
Locked Locked Locked
Next-generation gene editing tools are developed for drug enhancement.
Locked Locked Locked
Genetic therapies for diseases are developed using prime editing technology.
Locked Locked Locked
A CRISPR-based gene-editing platform is developed for therapeutic applications.
Premium access

Detailed competitors of ICBiotec

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Icbiotec

eGenesis Acquires ICBiotec
Pharmoutsourcing6 years ago
Premium access

Complete news archive for ICBiotec

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ICBiotec

ICBiotec was founded in 1998.

ICBiotec is headquartered in Mount Horeb, United States. It is registered at Mount Horeb, Wisconsin, United States.

ICBiotec was established in 1998 in Mount Horeb, United States. A gene editing platform is offered by the company within the biotechnology sector for advancing human-compatible organs, tissues, and cells. Operations are centered on genetic engineering tools and services that support regenerative medicine applications. Focus is placed on research and development activities conducted from the U.S. base, with relevance to therapeutic advancements in organ transplantation and tissue engineering.

ICBiotec's top competitors include eGenesis, Tessera Therapeutics and Korro Bio.

ICBiotec has 1 investor. Key investors include eGenesis.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available